Observational Study
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Oct 14, 2014; 20(38): 13999-14003
Published online Oct 14, 2014. doi: 10.3748/wjg.v20.i38.13999
Table 2 Study variables and the presence of bacterial overgrowth (univariate analysis) n (%)
Bacterial overgrowth
P value
YES 18 (16.8)NO 89 (83.2)
Time since disease diagnosis (yr)9.5 ± 7.18.4 ± 7.4NS
Age (yr)47 ± 17.839.5 ± 10.3NS
BMI (kg/m2)25 ± 6.225.2 ± 4.6NS
Ileal location17 (94.4)75 (84.3)NS
Pattern
Inflammatory2 (11.1)27 (30.3)NS
Stenotic10 (55.5)48 (53.9)NS
Fistulizing6 (33.3)14 (15.7)NS
Ileocecal valve resection12 (66.6)51 (57.3)NS
Treatment
Immunosuppressant12 (66.6)50 (56.2)NS
Biological2 (11.1)19 (21.3)NS
Double (immunosuppressant + biological)1 (5.5)12 (13.5)NS
Proton pump inhibitors4 (22.2)15 (16.9)NS
Presence of symptoms13 (72.2)42 (47.2)NS
Abdominal pain6 (33.3)36 (40.4)NS
Abdominal distension9 (50)43 (48.3)NS
Meteorism12 (66.6)37 (41.6)< 0.05
Borborygmus11 (61.1)42 (47.2)NS
Bowel frequency (24 h)3.1 ± 1.82.8 ± 2.1NS